United States · FDA National Drug Code directory
Spironolactone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 53746-515_0b757d66-e1f0-4d56-bbe0-2f0941f0a35e
- Product NDC
- 53746-515
- Form
- TABLET
- Composition / generic term
- Spironolactone
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100802
- Source listing expiry
- 20261231
Source-listed ingredients
- SPIRONOLACTONE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (53746-515-01) · 53746-515-01
- 500 TABLET in 1 BOTTLE (53746-515-05) · 53746-515-05
- 1000 TABLET in 1 BOTTLE (53746-515-10) · 53746-515-10
- 30 TABLET in 1 BOTTLE (53746-515-30) · 53746-515-30
- 60 TABLET in 1 BOTTLE (53746-515-60) · 53746-515-60
- 90 TABLET in 1 BOTTLE (53746-515-90) · 53746-515-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →